SOURDIVE; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for SOURDIVE; David.The latest application filed is for "cellular immunotherapy for repetitive administration".

Company Profile

2.4.17

SOURDIVE; David - Levallois-Perret FR
Sourdive; David - Levallois FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cellular Immunotherapy For Repetitive Administration App 20220233588 - SOURDIVE; David ; et al.	2022-07-28
Chimeric Antigen Receptors (car)-expressing Cells And Combination Treatment For Immunotherapy Of Patients With Relapse Refractory Adverse Genetic Risk Aml App 20210268028 - DEPIL; Stephane Andre ; et al.	2021-09-02
Method of engineering chemotherapy drug resistant T-cells for immunotherapy Grant 10,813,951 - Valton , et al. October 27, 2	2020-10-27
Method for generating batches of allogeneic T-cells with averaged potency Grant 10,357,515 - Sourdive , et al. July 23, 2	2019-07-23
Method For Generating T-cells Compatible For Allogenic Transplantation App 20190010514 - POIROT; Laurent ; et al.	2019-01-10
Modified diatoms for biofuel production Grant 10,087,453 - Duchateau , et al. October 2, 2	2018-10-02
Method For Generating T-cells Compatible For Allogenic Transplantation App 20170016025 - POIROT; Laurent ; et al.	2017-01-19
Method Of Engineering Chemotherapy Drug Resistant T-cells For Immunotherapy App 20160361359 - VALTON; Julien ; et al.	2016-12-15
Method For Generating Batches Of Allogeneic T-cells With Averaged Potency App 20160296563 - SOURDIVE; David ; et al.	2016-10-13
Modified Diatoms For Biofuel Production App 20160130599 - DUCHATEAU; Philippe ; et al.	2016-05-12
Method To Counter-select Cells Or Organisms By Linking Loci To Nuclease Components App 20150353885 - Sourdive; David	2015-12-10
Meganucleases Variants Cleaving A Dna Target Sequence In The Nanog Gene And Uses Thereof App 20130189759 - Sourdive; David	2013-07-25
Method For Targeted Genomic Events In Algae App 20130164850 - Sourdive; David	2013-06-27
Custom-made Meganuclease And Use Thereof App 20120159659 - Arnould; Sylvain ; et al.	2012-06-21
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof App 20110287513 - Arnould; Sylvain ; et al.	2011-11-24
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof App 20110151539 - Arnould; Sylvain ; et al.	2011-06-23
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Grant 7,842,489 - Arnould , et al. November 30, 2	2010-11-30
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof App 20100144012 - ARNOULD; Sylvain ; et al.	2010-06-10
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof App 20060153826 - Arnould; Sylvain ; et al.	2006-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.